ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Crescendo links with CRUK to progress cancer therapy pharmatimes
May 06, 2020Crescendo Biologics and Cancer Research UK have entered into a Clinical Development Partnership to progress one of Crescendo’s novel bispecific Humabody immunotherapies, CB213, into clinical trials targeting cancers of high unmet medical need.
Pharma Sources Insight January 2025
